http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2010098080-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06
filingDate 2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-WO2010098080-A1
titleOfInvention 1,4-Benzothiazepine-1-oxide derivative and pharmaceutical composition using the same
abstract As a therapeutic or preventive for heart failure, heart failure due to diastolic failure, left ventricular diastolic dysfunction, angina or myocardial infarction, hypertension, or ischemic heart disease, heart failure, atrial fibrillation or ventricular arrhythmia Useful novel compounds and pharmaceutical compositions containing the same are provided. The present invention relates to a 1,4-benzothiazepine-1-oxide derivative represented by the following general formula [I] (wherein R represents a hydrogen atom or a hydroxyl group) or a pharmaceutically acceptable salt thereof, And a pharmaceutical composition containing the same.
priorityDate 2009-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414182431

Total number of triples: 17.